West Pharmaceutical Services WST
NYSE WST
$413.09 +13.09 (+3.27%)
At close: Nov 9, 2026 · 4:00 PM EST

West Pharmaceutical Services (WST) Income from Continuing Operations (2009 - 2026)

Updated

West Pharmaceutical Services (WST) reported Income from Continuing Operations of $209.7 million for Q3 2026, up 52.1% from $137.9 million a year earlier and up 41.8% from the prior quarter.

Analysis

West Pharmaceutical Services (WST) Income from Continuing Operations (2009 - 2026) Analysis & Trends

Over the twelve months ended Sep 30, 2026, West Pharmaceutical Services' Income from Continuing Operations came in at $621.2 million, up 29.6% year-over-year; for FY2025, it came in at $479.3 million, up 0.3% from FY2024.

  • Income from Continuing Operations has a five-year compound annual growth rate of 7.8% (FY2020 to FY2025).
  • By year, Income from Continuing Operations came in at $478 million in FY2024 (-17.0%), $575.7 million in FY2023 (+1.9%), $565.2 million in FY2022 (-11.9%) and $641.7 million in FY2021 (+95.2%).
  • The Q3 2026 figure ranks as the highest quarterly Income from Continuing Operations in data going back to Q2 2009.
  • Year over year, Income from Continuing Operations has now increased in each of the last six quarters, with growth averaging 15.3% over the last eight quarters.
  • The high point for year-over-year Income from Continuing Operations in five years was Q1 2026 (growth of 56.7%); the low point was Q4 2022 (a decline of 32.4%).
  • Per Business Quant data, the three quarters before Q3 2026 came in at $147.9 million (Q2 2026), $135.4 million (Q1 2026) and $128.2 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Thermo Fisher Scientific 267.71 Bn 244.23 Bn 5.13 Bn 1.74 Bn
2 Abbott Laboratories 191.69 Bn 165.56 Bn 7.39 Bn 920.00 Mn
3 Danaher 166.18 Bn 145.83 Bn 3.84 Bn 1.21 Bn
4 Intuitive Surgical 161.07 Bn 141.36 Bn 2.08 Bn 524.40 Mn
5 Medtronic 131.65 Bn 96.90 Bn 6.34 Bn 1.48 Bn
6 Stryker 125.25 Bn 111.44 Bn 4.25 Bn -237.00 Mn
7 Boston Scientific 63.85 Bn 59.29 Bn 3.43 Bn 580.00 Mn
8 Edwards Lifesciences 60.52 Bn 43.72 Bn 1.35 Bn 301.40 Mn
9 Becton Dickinson 59.08 Bn 56.23 Bn 2.32 Bn 451.00 Mn
10 West Pharmaceutical Services 29.14 Bn 26.93 Bn 347.40 Mn 209.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 209.70 Mn
Jun 30, 2026 147.90 Mn
Mar 31, 2026 135.40 Mn
Dec 31, 2025 128.20 Mn
Sep 30, 2025 137.90 Mn
Jun 30, 2025 126.80 Mn
Mar 31, 2025 86.40 Mn
Dec 31, 2024 128.10 Mn
Sep 30, 2024 132.10 Mn
Jun 30, 2024 106.80 Mn
Mar 31, 2024 111.00 Mn
Dec 31, 2023 133.70 Mn
Sep 30, 2023 157.60 Mn
Jun 30, 2023 150.10 Mn
Mar 31, 2023 134.30 Mn
Dec 31, 2022 99.80 Mn
Sep 30, 2022 115.80 Mn
Jun 30, 2022 183.00 Mn
Mar 31, 2022 166.60 Mn
Dec 31, 2021 147.70 Mn
API Access

West Pharmaceutical Services Income from Continuing Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=WST&period=max&api_key=YOUR_API_KEY